Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.63 USD | +9.48% | +24.23% | +52.93% |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
May. 22 | Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.93% | 560M | |
+8.92% | 114B | |
+10.48% | 105B | |
-3.17% | 21.73B | |
-6.45% | 23.83B | |
-10.67% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target